Vetoquinol S.A. | Mid-cap | Healthcare
€74.40
-1.06%
| Vetoquinol S.A Stock Comparison:
Vetoquinol S.A vs Ipsen S.AVetoquinol S.A vs Boiron S.AVetoquinol S.A vs Euroapi S.A.S.UVetoquinol S.A vs AB Science S.AVetoquinol S.A vs CoreTech LimitedVetoquinol S.A vs CAC 40 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 744.1M
Total Liabilities 168.2M
Shareholders Equity 575.9M
Debt to Equity 0.29

Cash Flow Metrics

Revenue & Profitability Trend

Vetoquinol S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i539.2M529.3M539.8M521.3M427.5M
Cost of Goods Sold i151.7M156.6M159.6M150.7M129.8M
Gross Profit i387.4M372.6M380.1M370.5M297.6M
Gross Margin % i71.9%70.4%70.4%71.1%69.6%
Operating Expenses
Research & Development i2.4M1.8M2.8M2.9M3.1M
Selling, General & Administrative i102.2M96.2M95.5M93.5M69.4M
Other Operating Expenses i5.3M12.2M11.4M6.1M10.7M
Total Operating Expenses i109.9M110.2M109.8M102.4M83.2M
Operating Income i76.3M77.8M84.3M85.8M56.4M
Operating Margin % i14.1%14.7%15.6%16.5%13.2%
Non-Operating Items
Interest Income i5.9M3.3M807.0K366.0K623.0K
Interest Expense i1.1M918.0K999.0K617.0K827.0K
Other Non-Operating Income-----
Pre-tax Income i81.0M76.9M72.7M86.5M35.6M
Income Tax i22.3M21.3M24.7M23.8M16.6M
Effective Tax Rate % i27.6%27.7%34.0%27.5%46.8%
Net Income i58.7M55.6M48.0M62.9M19.2M
Net Margin % i10.9%10.5%8.9%12.1%4.5%
Key Metrics
EBITDA i113.0M115.8M116.9M119.5M83.2M
EPS (Basic) i€4.98€4.70€4.06€5.31€1.63
EPS (Diluted) i€4.98€4.70€4.06€5.31€1.63
Basic Shares Outstanding i1179567311832510118315881182776211826157
Diluted Shares Outstanding i1179567311832510118315881182776211826157

Income Statement Trend

Vetoquinol S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i206.3M147.5M93.7M69.0M129.4M
Short-term Investments i-----
Accounts Receivable i86.8M89.3M74.6M77.5M72.7M
Inventory i112.3M103.5M116.1M111.6M85.5M
Other Current Assets5.0K1.0K---1.0K
Total Current Assets i421.2M363.4M308.6M273.7M307.2M
Non-Current Assets
Property, Plant & Equipment i17.8M21.3M17.0M18.0M19.3M
Goodwill i294.9M304.1M321.1M345.4M334.7M
Intangible Assets i142.1M154.0M168.7M178.5M175.0M
Long-term Investments-----
Other Non-Current Assets----1.0K
Total Non-Current Assets i323.0M328.8M343.2M350.9M338.9M
Total Assets i744.1M692.2M651.8M624.6M646.1M
Liabilities
Current Liabilities
Accounts Payable i39.4M42.0M39.0M46.9M41.5M
Short-term Debt i9.9M8.0M7.9M8.3M116.6M
Current Portion of Long-term Debt-----
Other Current Liabilities1.0K2.0K11.0K9.0K251.0K
Total Current Liabilities i141.5M139.4M140.7M157.0M239.6M
Non-Current Liabilities
Long-term Debt i11.2M9.7M9.6M7.1M8.3M
Deferred Tax Liabilities i6.0M7.2M8.0M8.3M8.4M
Other Non-Current Liabilities684.0K721.0K817.0K825.0K6.1M
Total Non-Current Liabilities i26.7M25.7M26.5M26.2M34.7M
Total Liabilities i168.2M165.1M167.2M183.2M274.3M
Equity
Common Stock i29.7M29.7M29.7M29.7M29.7M
Retained Earnings i58.7M55.6M48.0M62.9M19.2M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i575.9M527.1M484.7M441.4M371.8M
Key Metrics
Total Debt i21.1M17.6M17.4M15.4M124.9M
Working Capital i279.6M224.0M167.9M116.7M67.6M

Balance Sheet Composition

Vetoquinol S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i58.7M55.6M48.0M62.9M19.2M
Depreciation & Amortization i-----
Stock-Based Compensation i0051.0K129.0K78.0K
Working Capital Changes i00000
Operating Cash Flow i54.7M54.3M48.8M90.0M19.8M
Investing Activities
Capital Expenditures i-12.5M-14.8M-16.4M-32.1M-10.2M
Acquisitions i00904.0K-1.2M0
Investment Purchases i-47.0K-10.0K-504.0K-74.0K0
Investment Sales i----141.0K
Investing Cash Flow i-12.5M-14.8M-16.0M-33.4M-10.0M
Financing Activities
Share Repurchases i-2.9M000-243.0K
Dividends Paid i-10.1M-9.5M-9.5M-5.9M-4.5M
Debt Issuance i845.0K1.0M2.2M1.5M112.1M
Debt Repayment i-1.9M-2.6M-2.4M-110.6M-89.0K
Financing Cash Flow i-8.9M-8.9M-9.4M-114.9M107.6M
Free Cash Flow i68.1M70.4M40.4M57.3M-53.2M
Net Change in Cash i33.2M30.7M23.4M-58.3M117.4M

Cash Flow Trend

Vetoquinol S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 14.94
Forward P/E 14.14
Price to Book 1.52
Price to Sales 1.65
PEG Ratio 2.51

Profitability Ratios

Profit Margin 10.88%
Operating Margin 16.28%
Return on Equity 10.64%
Return on Assets 6.66%

Financial Health

Current Ratio 2.98
Debt to Equity 3.67
Beta 0.75

Per Share Data

EPS (TTM) €4.98
Book Value per Share €48.82
Revenue per Share €45.71

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
veto887.3M14.941.5210.64%10.88%3.67
Ipsen S.A 8.9B19.702.0710.89%11.91%22.74
Boiron S.A 368.1M32.620.972.95%2.33%3.96
Euroapi S.A.S.U 276.1M8.840.28-13.49%-14.08%7.17
AB Science S.A 84.5M-8.93-32.97%116.42%-0.78
CoreTech Limited 3.1M---102.42%137.36%-0.95

Financial data is updated regularly. All figures are in the company's reporting currency.